MENU
ACIU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
AC Immune SA (ACIU) Ownership - Who owns AC Immune SA?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
290.89M
P/E Ratio
N/A
Total Cash
157.9M
Projected Growth
N/A
Total Debt
3.08M
Revenue
40.97M
Risk (Beta)
1.28
Dividend Yield
N/A
Total Cash/Share
1.60
Total Debt/Equity
N/A
Revenue/Share
0.48 USD as % of share price
Fundamentals
ACIU
Capitalization
291M
P/E Ratio
N/A
Risk (Beta)
1.28
Dividend Yield
N/A
Total Cash
158M
Total Cash/Share
1.60
Total Debt
3.08M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.48%
Revenue
41M
ROE
N/A
Book Value
130M
P/B Ratio
2.00
Cash Flow
N/A
Earnings
-0.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.22M
Current Ratio
1.86
Current Revenue Per Employee
158291.92
Dividends Per Share - Security
N/A
EBITDA
-37.55M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-20.59
Shares Held By Institutions
121M
Shares Outstanding - Current
98.9M
Total Liabilities
114M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-41.200
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com